US23918K1088 - Common Stock
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
/PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2,...
Even with $300, many Buffett investments are within reach of the average investor.
/PRNewswire/ -- DaVita Inc. today announced that its Board of Directors has appointed a new independent director, Dennis Pullin, to join the Board, effective...
These are three great ways to get income in your portfolio without the hard work of choosing stocks and bonds on your own.
Berkshire even lists one of these companies as a subsidiary.
Strong brands and market presence make these three companies attractive investments.
/PRNewswire/ -- Today, The American Diabetes Association ® (ADA) and DaVita (NYSE: DVA), a leading provider of kidney care services, announced the expansion of...
/PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations,...
Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease.
/CNW/ -- DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today announced that it has agreed to terms on the expansion of its international...
/PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations,...
Dive into the world of investing with cheap stocks DaVita, Altria, and StoneCo as they show potential growth.
The dialysis services company handily beat expectations with its latest quarter.
DVA earnings call for the period ending December 31, 2023.
Financial writer reports DaVita's Q4 results: Non-GAAP EPS beats by $0.21 at $1.87, revenue beats by $140M at $3.15B.
/PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2023. "As we reflect on the past...
This stock isn't cheap because it's performed poorly over the past 12 months.
You don't need to have millions of dollars to invest in quality businesses.